Fluorescent imaging with cetuximab safely used in glioblastoma patients
Antibody-based infrared fluorescent imaging can specifically distinguish cancer from normal tissue in patients with glioblastoma...
List view / Grid view
Antibody-based infrared fluorescent imaging can specifically distinguish cancer from normal tissue in patients with glioblastoma...
Researchers have identified the molecular mechanism that causes kidney cancer to resist drug treatment...
Mutations in the APC gene, harm the immune system, leaving it unable to tackle inflammation thereby favouring the development of cancer...
New research suggests that the lung microbiome plays a significant role in asthma severity and response to treatment...
Scientists have developed 'intelligent' nanoparticles which heat up to a temperature high enough to kill cancerous cells...
Scientists have identified five targets that reduce the parasite's ability to invade red blood cells...
Researchers have built a synthetic genetic tool yTRAP to quantitatively sense, measure and manipulate protein aggregation in live cells...
By developing a chemical to inhibit β-lactamase enzymes, a significant proportion of antibiotic resistance may successfully be reversed...
Nuclease-free gene editing has been found to correct mutated cells ...
Researchers have reported a major step forward towards designing more powerful psychiatric drugs with fewer side effects...
Researchers identify binding site on the amyloid beta peptide that could facilitate better drugs to treat the disease...
Researchers have performed meta-analysis of neurological and neurodegenerative diseases and created an atlas of how cell characteristics are linked to their genotype...
Researchers have analysed a rare peripheral T-cell lymphoma that may develop as a result of breast implants...
Didehydro-Cortistatin A effectively suppresses production of the HIV virus in chronically infected cells and prevents viral rebound...
Researchers have developed a synthetic compound that targets the enzyme FerT, thereby killing metastatic cells...